KCL study reveals particles in cows’ milk effective for oral delivery of RNA drugs
The method has the potential to be used to deliver RNA to the bloodstream for a range of diseases
Read Moreby Jen Brogan | Apr 29, 2024 | News | 0
The method has the potential to be used to deliver RNA to the bloodstream for a range of diseases
Read Moreby Selina McKee | Jun 4, 2020 | News | 0
These proteins control various aspects of RNA biology and represent a new target for cancer treatment
Read Moreby Selina McKee | Nov 9, 2017 | News | 0
Boehringer Ingelheim has signed a second deal focused on the development of RNA therapeutics for liver diseases.
Read Moreby Selina McKee | Jun 29, 2016 | News | 0
Cambridge University spin-off Storm Therapeutics has secured £12 million in series ‘A’ funding to advance its work on targeting enzymes that modify RNA to generate novel cancer therapeutics.
Read More





PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
